Literature DB >> 16882551

Oral gene delivery: Strategies to improve stability of pDNA towards intestinal digestion.

Brigitta Loretz1, Florian Föger, Martin Werle, Andreas Bernkop-Schnürch.   

Abstract

PURPOSE: Gastrointestinal (GI) nucleases are responsible for a rapid presystemic degradation of orally administered transgenes. Within the current study, the activity of these degrading enzymes as well as the effect of various nuclease inhibitors on the degradation process were evaluated in order to assess their potential as auxiliary agents in oral gene delivery.
METHODS: Digestion assays of pDNA with DNaseI and in GI juices were performed in absence and presence of inhibitors. Consequently, a chitosan conjugate with covalently bound ethylendiaminetetraacetic acid disodium salt dihydrat (EDTA) was synthesized and its nuclease inhibitory properties were evaluated.
RESULTS: Small intestinal juice was shown to possess a nuclease activity per millilitre corresponding to 0.02 Kunitz units of DNaseI. Inhibition studies revealed that inhibitory activity followed the ranking: EDTA > sodium dodecyl sulfate (SDS) > aurintricarboxylic acid (ATA) > poly (acrylic acid) > cysteine. The chitosan-EDTA conjugate offered good nuclease inhibiting properties.
CONCLUSION: This study determined the nuclease activity of native porcine small intestinal juice as well as enterocytes homogenate. Moreover, several promising strategies to overcome this enzymatic barrier were identified.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882551     DOI: 10.1080/10611860600823766

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  10 in total

Review 1.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

Review 2.  Oral Delivery of Nucleic Acid Therapies for Local and Systemic Action.

Authors:  Neha Kumari; Kasturi Siddhanta; Sudipta Panja; Vineet Joshi; Chinmay Jogdeo; Ekta Kapoor; Rubayat Khan; Sai Sundeep Kollala; Balawant Kumar; Diptesh Sil; Amar B Singh; Daryl J Murry; David Oupický
Journal:  Pharm Res       Date:  2022-10-21       Impact factor: 4.580

Review 3.  Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Authors:  Iyyakkannu Sivanesan; Shadma Tasneem; Nazim Hasan; Juhyun Shin; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Polymers (Basel)       Date:  2022-05-24       Impact factor: 4.967

4.  Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.

Authors:  Mayank D Bhavsar; Mansoor M Amiji
Journal:  AAPS PharmSciTech       Date:  2008-01-18       Impact factor: 3.246

5.  Measuring the process and rate of exogenous DNA degradation during digestion in mice.

Authors:  Ruiqi Xing; Hui Liu; Xia Qi; Lingzi Pan
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

6.  Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus.

Authors:  Seungbin Cha; Sun Hwa Lee; Sung Hun Kang; Mohammad Nazmul Hasan; Young Jun Kim; Sungpil Cho; Yong-Kyu Lee
Journal:  Biomater Res       Date:  2018-07-27

7.  The association between faecal host DNA or faecal calprotectin and feed efficiency in pigs fed yeast-enriched protein concentrate.

Authors:  K R Slinger; A H Stewart; Z C T R Daniel; H Hall; H V Masey O'Neill; M R Bedford; T Parr; J M Brameld
Journal:  Animal       Date:  2019-05-07       Impact factor: 3.240

Review 8.  Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems.

Authors:  Deepak A Subramanian; Robert Langer; Giovanni Traverso
Journal:  J Nanobiotechnology       Date:  2022-08-06       Impact factor: 9.429

9.  Fabrication and characterization of DNA-loaded zein nanospheres.

Authors:  Mary C Regier; Jessica D Taylor; Tyler Borcyk; Yiqi Yang; Angela K Pannier
Journal:  J Nanobiotechnology       Date:  2012-12-02       Impact factor: 10.435

Review 10.  Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease.

Authors:  Xiao-Ying Si; Didier Merlin; Bo Xiao
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.